Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-21

Clinical Trial Update: Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication [Phase 2, Phase 3]

View source ↗

Summary

A head-to-head Phase 2/3 clinical trial comparing tegoprazan 50 mg twice daily plus amoxicillin 1 g three times daily with vonoprazan 20 mg twice daily plus amo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • Tegoprazan (tegoprazan)
  • Vonoprazan (vonoprazan)

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: Helicobacter Pylori Infection | Phase 2, Phase 3 | Status: RECRUITING